Peptidyl-threonine modification

pathway activity — cross-omics
GO:0018210Cross-omicsPROTEIN-MS → RNACellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Peptidyl-threonine modification pathway is significantly associated with the RNA expression of multiple genes, with the BREAST cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are HINFP, C11orf95, and AS3MT, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Peptidyl-threonine modification activity versus HINFP in BREAST (Pearson r = 0.35).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BREASTHINFP →+0.570+0.557.002.00135
BREASTC11orf95 →+0.874+0.452<.001.00134
BREASTAS3MT →+1.788+0.422<.001.00234
BONEJKAMP →-0.895-0.300<.001<.00134
KIDNEYSAMD11 →+2.343+0.259.001.00133
KIDNEYTIGAR →-1.546-0.230.002.00633
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0018210 vs HINFP — BREAST

Per-sample scatter of Peptidyl-threonine modification activity vs HINFP in BREAST.

Explore this scatter interactively →

Exploration